Liver Transplantation: Immunosuppression, Prognostic Factors, Survival, and Technological Advances
1University of São Paulo, São Paulo, Brazil
2University of Barcelona, Barcelona, Spain
3University of Louvain, Brussels, Belgium
4Stanford University, Stanford, USA
Liver Transplantation: Immunosuppression, Prognostic Factors, Survival, and Technological Advances
Description
The selection of appropriate liver donors and recipients for liver transplants remains a critical component of the success of the procedure. Previous studies have demonstrated the relevance of various options for the optimal selection of both donors and recipients. It is clear also, however, that factors such as the risk of mortality on the waiting list and the scarcity of organ supply worldwide may also impact selection criteria.
Over recent years, the standardization of surgical techniques, anesthetic procedures, preoperative and postoperative intensive care, and postoperative follow-up have together resulted in significant improvements in the success of the entire liver transplantation process. Various advances, such as harvesting techniques with the use of perfusion machines, small-for-size syndrome studies, use of living donors, and advances in medical therapies, should lead to further improvements in the survival of both the liver graft and the patient.
Considering these points, this Special Issue invites authors to submit original research, clinical studies, and review articles that focus on progress in surgical techniques, pharmaceutical interventions, and technological advances that should enable significant improvements in tissue microarchitecture, function, survival, and outcomes after liver transplantation.
Potential topics include but are not limited to the following:
- Immunosuppression in liver transplantation
- Living donor liver transplantation
- Small-for-size syndrome
- Prognostic factors in liver transplantation
- Survival and technological advances in liver transplantation